Kiyoshi Tadano

A Novel Class of Cycloalkano[<i>b</i>]pyridines as Potent and Orally Active Opioid Receptor-like 1 Antagonists with Minimal Binding Affinity to the hERG K⁺Channel

Takashi Yoshizumi, Hirobumi Takahashi, Hiroshi Miyazoe et al. · Journal of Medicinal Chemistry · 2008 · 25 citations · Full text

Vivo Antagonism, Molecular Pharmacology, Medicinal Chemistry +14

Cardiotoxicity assessment using 3D vascularized cardiac tissue consisting of human iPSC-derived cardiomyocytes and fibroblasts

Kiyoshi Tadano, Shigeru Miyagawa, Maki Takeda et al. · Molecular Therapy — Methods & Clinical Development · 2021 · 23 citations · Full text

Discovery of pyridone-containing imidazolines as potent and selective inhibitors of neuropeptide Y Y5 receptor

Makoto Ando, Nagaaki Sato, Tsuyoshi Nagase et al. · Bioorganic & Medicinal Chemistry · 2009 · 21 citations · Full text

Biochemistry, Pyridone-containing Imidazolines, Medicine +9

EFFECTS OF SARAFOTOXIN S6c ON RENAL HAEMODYNAMICS AND URINE FORMATION IN ANAESTHETIZED DOGS

G Matsuo, Yasuo Matsumura, Kiyoshi Tadano et al. · Clinical and Experimental Pharmacology and Physiology · 1997 · 20 citations

Sarafotoxin S6c, Renal Function, Sodium Homeostasis +9

Involvement of Nitric Oxide in Endothelin ETB Receptor-Mediated Inhibitory Actions on Antidiuresis and Norepinephrine Overflow Induced by Stimulation of Renal Nerves in Anesthetized Dogs

Gen Matsuo, Yasuo Matsumura, Kiyoshi Tadano et al. · Journal of Cardiovascular Pharmacology · 1997 · 20 citations